SCHULTES BIRGIT C

PrivateCIK: 2051419
Location

CAMBRIDGE, MA

SCHULTES BIRGIT C enters INTELLIA THERAPEUTICS, INC. with 67.61K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderSCHULTES BIRGIT CCIK 2051419
Officer· EVP, Chief Scientific Officer
Since Mar 2026
67.61K
Baseline shares
100% direct
67.61K
Direct ownership
1 position
181.51K
Derivative underlying
8 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned67.61K
Total
67.61K direct67.61K
Derivative Holdings8

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

20K

Shares owned

N/A

Exercise price

18.3

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

3.50K

Shares owned

N/A

Exercise price

134.06

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

31.82K

Shares owned

N/A

Exercise price

32.66

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

24.96K

Shares owned

N/A

Exercise price

40.75

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

10.63K

Shares owned

N/A

Exercise price

14.58

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

20.60K

Shares owned

N/A

Exercise price

57.71

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

40K

Shares owned

N/A

Exercise price

27.33

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

30K

Shares owned

N/A

Exercise price

13.4

Expiration

Exercise window

Total

Underlying

181.51K

Owned

0.00

SCHULTES BIRGIT C — Initial Ownership Disclosure (Form 3) Filed Jan 23, 2025 | Finecho